» Articles » PMID: 38239497

Fractalkine Modulates Pulmonary Angiogenesis and Tube Formation by Modulating CX3CR1 and Growth Factors in PVECs

Overview
Journal Open Life Sci
Specialty Biology
Date 2024 Jan 19
PMID 38239497
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to investigate effects of pulmonary fractalkine (FKN/CX3CL1) on angiogenesis and tube formation. Tube forming capability of pulmonary vascular endothelial cells (PVECs) was evaluated. CCK-8 assay was used to evaluate proliferation of PVECs. RT-PCR assay was used to determine angiogenesis specific biomarkers. Western blot was applied to identify CX3CR1, Akt, phosphorylated Akt (p-Akt), Erk1/2, phosphorylated Erk1/2 (p-Erk1/2), vascular endothelial growth factor A (VEGFA), and inducible nitric oxide synthase (iNOS) expression. VEGF-A and platelet-derived growth factor (PDGF) levels were examined using ELISA. FKN was safe and triggered tube formation in PVECs. FKN significantly enhanced VEGF-A, PDGF, and iNOS gene transcription compared to the Control group ( < 0.05). CX3CR1 interfering (LV5-CX3CR1 shRNA) remarkably reduced CX3CR1 expression compared to those in LV5 blank group ( < 0.05). Ratios of p-Akt/Akt and p-Erk/Erk were significantly decreased in CX3CR1 shRNA-treated PVECs administered Akt inhibitor (or Erk inhibitor) and 10 ng/mL FKN compared to CX3CR1 shRNA-treated PVECs administered 10 ng/mL FKN ( < 0.05). FKN increased VEGF-A and iNOS expression through activating Akt/Erk pathway. FKN promoted VEGF-A/iNOS expression and triggered p-Akt/Akt and p-Erk/Erk pathway through modulating CX3CR1. FKN-treated macrophages enhanced activation of Akt/Erk pathway. FKN-treated macrophages enhanced PDGF and VEGF-1 expression in PVECs. FKN modulated pulmonary angiogenesis and tube formation through modulating CX3CR1 and growth factors and activating p-Akt/Akt and p-Erk/Erk signaling pathway.

References
1.
Rowinska Z, Koeppel T, Sanati M, Schelzig H, Jankowski J, Weber C . Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation. PLoS One. 2017; 12(2):e0170644. PMC: 5325192. DOI: 10.1371/journal.pone.0170644. View

2.
Dohan Ehrenfest D, Pinto N, Pereda A, Jimenez P, Del Corso M, Kang B . The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane. Platelets. 2017; 29(2):171-184. DOI: 10.1080/09537104.2017.1293812. View

3.
Eriksson E . Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects. Curr Opin Lipidol. 2004; 15(5):553-8. DOI: 10.1097/00041433-200410000-00009. View

4.
Lucas A, Chadwick N, Warren B, Jewell D, Gordon S, Powrie F . The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol. 2001; 158(3):855-66. PMC: 1850344. DOI: 10.1016/S0002-9440(10)64034-5. View

5.
Gu H, Zuo S, Liu H, Gu L, Yang X, Liao J . CX3CR1 participates in pulmonary angiogenesis in experimental hepatopulmonary syndrome mice through inhibiting AKT/ERK signaling pathway and regulating NO/NOS release. Eur Rev Med Pharmacol Sci. 2019; 23(15):6645-6656. DOI: 10.26355/eurrev_201908_18555. View